Cinnamon extract tested as natural labor starter in new trial
NCT ID NCT06164613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a cinnamon extract can safely and effectively start labor in full-term, first-time mothers. 70 participants will receive either the extract or a placebo, and researchers will measure how quickly labor begins and progresses. The goal is to see if this natural remedy can reduce the need for medical induction and cesarean sections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
14 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Delivery of an informed consent form signed and dated by parents or guardian and patient 2. Declared willingness to comply with all study procedures and availability for the duration of the study. 3. provision of appropriate consent and assent 4. Willingness and ability to participate in study procedures 5. Patients under 18 years of age 6. Full-term pregnancies (37-41 Weeks of Gestation). 7. Nulliparity 8. Have your own cell phone 9. Know how to read and write 10. Residing in Tegucigalpa 11. Be in good general health, as evidenced by your medical history 12. Ultrasound with amniotic fluid index \> 5 cm 13. Non Stress Test Reactive 14. Ability to take oral medication and be willing to comply with the cinnamon capsule regimen Exclusion Criteria: 1. Current use of antihypertensive or hypoglycemic medications 2. Presence of non-curable chronic diseases prior to pregnancy or during pregnancy such as hypertension, diabetes, hypothyroidism 3. Premature rupture of membranes 4. Infections (urinary tract infection, chorioamnionitis) present at the time of the study (diagnosed with symptoms or leukocytes \>12,500 or pathological urine examination) 5. Allergies to cinnamaldehyde or cinnamon, canola oil 6. Multiple pregnancy 7. Major fetal malformations 8. Fetal death 9. Non-cephalic presentation 10. Severe oligohydramnios (amniotic fluid index \< 2 cm) 11. Having consumed or being consuming cinnamon products 7 days before the start of the study 12. Febrile illness within 7 days before starting to take cinnamon 13. Treatment with another investigational drug or other intervention within 7 days prior to the start of the intervention 14. Current smoker or tobacco use
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for First birth are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Escuela
RECRUITINGTegucigalpa, Francisco Morazán Department, 11101, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.